Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Diabetes Pipeline Includes Insulin Patch, Next-Gen CGM

This article was originally published in The Gray Sheet

Executive Summary

Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch
Advertisement

Related Content

Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.
Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.
Diabetes Foundation, Device Firms Partner To Develop Artificial Pancreas
Diabetes Foundation, Device Firms Partner To Develop Artificial Pancreas
Good Algorithms, Documentation Needed For Artificial Pancreas Approval
Good Algorithms, Documentation Needed For Artificial Pancreas Approval
DexCom Deals Integrate Glucose Monitor With Insulin Pumps

Topics

Advertisement
UsernamePublicRestriction

Register

MT027529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel